insitro

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created. By generating massive, integrated multi-modal datasets of human and cellular data, the company builds 'Virtual Human' models—genetically anchored causal AI engines—to reveal disease mechanisms and identify novel therapeutic targets. The company's platform, which includes proprietary tools like ChemML and TherML, is designed to be modality-agnostic, spanning small molecules, antibodies, and complex biologics. insitro focuses its pipeline on areas with significant unmet needs, particularly neuroscience, metabolic diseases, and ophthalmology, aiming to increase the probability of clinical success through predictive modeling.